BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2017
View Archived Issues
ZFPM2 found as a gene for primary ovarian insufficiency
Read More
Pfizer announces European approval of the Meningococcal Group B vaccine Trumenba
Read More
VesiGel shows promise as alternative to resection in nonmuscle-invasive bladder cancer
Read More
Nippon Boehringer Ingelheim and Kobe University enter diabetes agreement
Read More
FDA clears IND for LOXO-195
Read More
Novel bile acid receptor agonist BAR-704 limits experimental liver fibrosis
Read More
Four phase III studies of bictegravir/emtricitabine/tenofovir alafenamide meet primary endpoints
Read More
Sanofi and ImmunoGen amend cancer immunotherapy agreements
Read More
University of Michigan begins phase I trial of oral heptapeptide KSP-910638G
Read More
Inspyr Therapeutics to merge with Lewis and Clark Pharmaceuticals to create novel integrated company
Read More
Asana BioSciences advances phase I/II study of ASN-002
Read More
i2 Pharmaceuticals acquires antibody and protein therapeutics portfolio
Read More
BAMBI inhibition is beneficial in autoimmune diseases
Read More
C1orf198 found to be a predictor of metastasis in bladder cancer
Read More
Wockhardt discloses compounds for treating bacterial infections
Read More
Daewoong Pharmaceutical presents Nav1.7 channel blockers
Read More
TD-139 well tolerated and affects biomarkers in idiopathic pulmonary fibrosis trial
Read More
AstraZeneca identifies MAPK1 inhibitors
Read More
Eisai presents AMPA receptor antagonists
Read More
Fennec launches European Named Patient Program for sodium thiosulfate
Read More
Zhejiang Hisun Pharmaceutical divulges estrogen receptor alpha modulators
Read More
FDA gives rare pediatric disease designation to EB-101 from Abeona
Read More
Ligand Pharmaceuticals enters agreement with xCella Biosciences
Read More
Phase III RANGE urothelial cancer study of ramucirumab meets primary endpoint
Read More
Array and Ono partner to develop and commercialize binimetinib and encorafenib
Read More